Severe CMV Colitis Management

Clinical Manifestations and Mortality

Severe CMV colitis carries an in-hospital mortality approaching 70% in immunocompetent patients and even higher in immunocompromised hosts, requiring immediate antiviral therapy with IV ganciclovir and early surgical consultation for life-threatening complications 1, 2
Fever and systemic toxicity develop as the disease progresses, signaling potential perforation or sepsis 1

Toxic megacolon represents a surgical emergency requiring immediate colectomy 1, 2
Colonic perforation occurs due to transmural necrosis from CMV-induced vasculitis 1, 2, 3
Fulminant colitis with systemic toxicity and hemodynamic instability 2, 3
Bowel ischemia from progressive vascular involvement 1, 3

Small bowel involvement occurs in up to 40% of CMV infections, helping differentiate from C. difficile colitis which spares the small bowel 1, 2
Pancolic distribution is rare, unlike C. difficile which shows pancolic thickening in 50% of cases 1

IV ganciclovir 5 mg/kg every 12 hours as first-line therapy for adults 1, 2, 3
Transition to oral valganciclovir 900 mg twice daily after 3-5 days of IV therapy for adults 1, 2, 3
Maintain parenteral ganciclovir for the full 14-21 day course without switching to oral therapy for pediatric patients 1, 2, 3
Initiate empiric broad-spectrum antibiotics immediately to cover bacterial translocation and secondary infection from bowel wall necrosis 1, 2
Consult surgery on admission given the 70% mortality rate even with treatment 1, 2
Proceed urgently to subtotal or partial colectomy if toxic megacolon, fulminant colitis, colonic perforation, or bowel ischemia develop 1, 2, 3

Seven-fold higher in-hospital mortality occurs when CMV colitis complicates inflammatory bowel disease 1, 2

The colon is the most common site of involvement in CMV enteritis, with colonic localization being the predominant manifestation of gastrointestinal CMV infection in immunocompromised patients 4, 5, 6
CMV colonic localization is explicitly stated as "the most common" site of gastrointestinal involvement, causing vasculitis that ultimately leads to bowel wall necrosis 4, 5, 6
The cecum and ileocecal valve region appear to be particularly affected, with some studies identifying typical cecum ulcers involving the ileocecal valve as a specific finding in CMV colitis, especially in patients with graft-versus-host disease 4, 5, 6

Colonoscopy with multiple biopsies remains the cornerstone diagnostic approach, with biopsies targeting ulcer bases and edges where CMV-positive cells are most concentrated 7, 8, 9
Pancolic appearance is rare and may help differentiate CMV colitis from other conditions like Clostridioides difficile colitis 4
The presence of small bowel thickening on CT scan (present in up to 40% of CMV infections) is absent in C. difficile colitis and can aid in differential diagnosis 4